Please login to Zacks.com or register to post a comment.
They're hand-picked from the list of Zacks Rank #1 Strong Buys. Our experts predict that their prices will jump the soonest.
Today, you can see them free.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| STAAR SURGIC | STAA | 10.98% |
| DTS INC | DTSI | 6.89% |
| ANIKA THERAP | ANIK | 6.04% |
| LUMOS NETWOR | LMOS | 5.70% |
| INSTEEL IND | IIIN | 5.28% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Strong sales and productivity savings facilitated The Hain Celestial Group Inc. (HAIN - Analyst Report) to post second-quarter 2013 adjusted earnings of 72 cents a share, up 35.8% from the prior-year quarter earnings of 53 cents. Moreover, earnings of this Zacks Rank #2 (Buy) company came ahead of the Zacks Consensus Estimate of 69 cents.
Including one-time items, earnings came in at 67 cents compared with 44 cents a share earned in the year-ago quarter.
Revenues
Net sales from continuing operations rose 24.8% year over year to $455.3 million, reflecting rise in demand for natural organic products. However, reported revenues missed the Zacks Consensus Estimate of $474 million.
Net sales in United States increased 9.4% year over year on a comparable basis to $280.4 million during the quarter, while net sales at United Kingdom more than doubled to $120.2 million. Rest of the World witnessed an 11.1% increase in net sales to $54.7 million.
The company registered elevated consumption in core categories with robust contribution from Garden of Eatin, MaraNatha, Celestial Seasonings, Earth's Best, Imagine, The Greek Gods, Lima, Alba Botanica, Danival and Linda McCartney. Hain Celestial also experienced solid sales across recently-acquired brands.
Margins
Gross profit ascended 25% year over year to $130.8 million during the quarter. However, gross margin remained flat at 28.7% as rise in sales were offset by increased input and commodity costs.
Adjusted operating profit jumped 33.8% to $55 million in the quarter, while adjusted operating margin expanded approximately 80 basis points to 12.1%, indicating productivity savings and improved sales mix.
Other Financial Details
The company ended the quarter with cash and cash equivalents of $42.6 million, long-term debt of $635.1 million and shareholders’ equity of $1,105.5 million.
Guidance
The company hopes to sustain strong momentum across entire business segments as it remains well positioned to capitalize on the growing global demand for organic products.
Alongside, the company anticipates sales to be in the range of $1,740 million – $1,755 million in fiscal 2013, reflecting an increase of 26% to 27%. Earnings are expected to be in the range of $2.40 – $2.47 a share, up 29% – 33% year over year.
Other Stocks to Consider
Besides Hain, other stocks in the processed & packaged goods industry worth considering include, Flowers Foods, Inc. (FLO - Snapshot Report), Ingredion Incorporated (INGR - Snapshot Report) and Inventure Foods, Inc. (SNAK - Snapshot Report) all holding a Zacks Rank #1 (Strong Buy).
Get the full Analyst Report on HAIN - FREE
Get the full Snapshot Report on INGR - FREE
Get the full Snapshot Report on SNAK - FREE
Get the full Snapshot Report on FLO - FREE